{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T10:50:04Z","timestamp":1790419804487,"version":"4.1.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,5,29]],"date-time":"2021-05-29T00:00:00Z","timestamp":1622246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,5,29]],"date-time":"2021-05-29T00:00:00Z","timestamp":1622246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurotox Res"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s12640-021-00378-2","type":"journal-article","created":{"date-parts":[[2021,5,29]],"date-time":"2021-05-29T06:03:38Z","timestamp":1622268218000},"page":"1352-1359","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Botulinum Injections for Idiopathic Cervical Dystonia: a Longitudinal Study"],"prefix":"10.1007","volume":"39","author":[{"given":"Gilad","family":"Yahalom","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsvia","family":"Fay-Karmon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vered","family":"Livneh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Israeli-Korn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilach","family":"Ephraty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Hassin-Baer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,29]]},"reference":[{"issue":"2","key":"378_CR1","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s12640-017-9737-6","volume":"32","author":"AR Bentivoglio","year":"2017","unstructured":"Bentivoglio AR, Di Stasio E, Mulas D, Cerbarano ML, Ialongo T, Laurienzo A, Petracca M (2017) Long-term abobotulinumtoxin a treatment of cervical dystonia. Neurotox Res 32(2):291\u2013300","journal-title":"Neurotox Res"},{"key":"378_CR2","doi-asserted-by":"publisher","first-page":"258","DOI":"10.3389\/fneur.2015.00258","volume":"6","author":"JS Butler","year":"2015","unstructured":"Butler JS, Beiser IM, Williams L, McGovern E, Molloy F, Lynch T, Healy DG, Moore H, Walsh R, Reilly RB, O\u2019Riordan S, Walsh C, Hutchinson M (2015) age-related sexual dimorphism in temporal discrimination and in adult-onset dystonia suggests GABAergic mechanisms. Front Neurol 6:258","journal-title":"Front Neurol"},{"issue":"Suppl. 2","key":"378_CR3","first-page":"51","volume":"15","author":"D Dressler","year":"2000","unstructured":"Dressler D, Dirnberger G (2000) Botulinum toxin therapy: risk factors for therapy failure. Mov Disord 15(Suppl. 2):51","journal-title":"Mov Disord"},{"key":"378_CR4","doi-asserted-by":"publisher","first-page":"S92","DOI":"10.1002\/mds.20022","volume":"8","author":"D Dressler","year":"2004","unstructured":"Dressler D (2004) Clinical presentation and management of antibody-induced failure of botulinum toxin therapy. Mov Disord 8:S92-100","journal-title":"Mov Disord"},{"issue":"4","key":"378_CR5","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s10072-009-0097-8","volume":"30","author":"AC Felicio","year":"2009","unstructured":"Felicio AC, Godeiro-Junior C, de Carvalho AP, Borges V, Silva SM, Ferraz HB (2009) Predictable variables for short- and long-term botulinum toxin treatment response in patients with cervical dystonia. Neurol Sci 30(4):291\u2013294","journal-title":"Neurol Sci"},{"issue":"1\u20132","key":"378_CR6","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jns.2015.06.015","volume":"355","author":"J Finsterer","year":"2015","unstructured":"Finsterer J, Maeztu C, Revuelta GJ, Reichel G, Truong D (2015) Collum-caput (COL-CAP) concept for conceptual anterocollis, anterocaput, and forward sagittal shift. J Neurol Sci 355(1\u20132):37\u201343","journal-title":"J Neurol Sci"},{"key":"378_CR7","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1212\/01.WNL.0000144349.95487.91","volume":"63","author":"MF Gordon","year":"2004","unstructured":"Gordon MF, Brashear A, Elovic E, Kassicieh D, Marciniak C, Liu J, Turkel C, BOTOX Poststroke Spasticity Study Group (2004) Repeated dosing of botulinum toxin type A for upper limb spasticity following stroke. Neurology 63:1971\u20131973","journal-title":"Neurology"},{"issue":"6","key":"378_CR8","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1111\/ane.13304","volume":"142","author":"V Han","year":"2020","unstructured":"Han V, Skorvanek M, Smit M, Turcanova Koprusakova M, Hoekstra T, van Dijk JP, Tijssen MAJ, Gdovinova Z, Reijneveld SA (2020) Prevalence of non-motor symptoms and their association with quality of life in cervical dystonia. Acta Neurol Scand 142(6):613\u2013622","journal-title":"Acta Neurol Scand"},{"key":"378_CR9","doi-asserted-by":"publisher","first-page":"588395","DOI":"10.3389\/fneur.2020.588395","volume":"11","author":"H Hefter","year":"2020","unstructured":"Hefter H, Schomaecker I, Schomaecker M, Samadzadeh S (2020) Disease progression of idiopathic cervical dystonia in spite of improvement after botulinum toxin therapy. Front Neurol 11:588395","journal-title":"Front Neurol"},{"issue":"1","key":"378_CR10","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1038\/s41598-020-58363-2","volume":"10","author":"L Hvizdo\u0161ov\u00e1","year":"2020","unstructured":"Hvizdo\u0161ov\u00e1 L, Nevrl\u00fd M, Otruba P, Hlu\u0161t\u00edk P, Ka\u0148ovsk\u00fd P, Zapletalov\u00e1 J (2020) The prevalence of dystonic tremor and tremor associated with dystonia in patients with cervical dystonia. Sci Rep 10(1):1436","journal-title":"Sci Rep"},{"issue":"8","key":"378_CR11","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1007\/s00415-019-09349-2","volume":"266","author":"A Jochim","year":"2019","unstructured":"Jochim A, Meindl T, Mantel T, Zwirner S, Zech M, Castrop F, Haslinger B (2019) Treatment of cervical dystonia with abo- and onabotulinumtoxin A: long-term safety and efficacy in daily clinical practice. J Neurol 266(8):1879\u20131886","journal-title":"J Neurol"},{"key":"378_CR12","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.jns.2019.02.017","volume":"399","author":"WH Jost","year":"2019","unstructured":"Jost WH, Schramm A, M\u00fcngersdorf M, Stenner A, Schwingenschuh P, Maisonobe P, Koch M, Haslinger B (2019) Effectiveness of botulinum neurotoxin type A injections in na\u00efve and previously-treated patients suffering from Torti- or Laterocollis or -caput: Results from a German-Austrian open-label prospective post-marketing surveillance study. J Neurol Sci 399:44\u201350","journal-title":"J Neurol Sci"},{"issue":"4","key":"378_CR13","first-page":"265","volume":"246","author":"KR Kessler","year":"1999","unstructured":"Kessler KR, Skutta M, Benecke R (1999) Long-term treatment of cervical dystonia with botulinum toxin A: efficacy, safety, and antibody frequency. German Dystonia Study Group. J Neurol 246(4):265\u2013274","journal-title":"German Dystonia Study Group. J Neurol"},{"issue":"3","key":"378_CR14","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1002\/mds.27927","volume":"35","author":"SC LaHue","year":"2020","unstructured":"LaHue SC, Albers K, Goldman S, Lo RY, Gu Z, Leimpeter A, Fross R, Comyns K, Marras C, de Kleijn A, Smit R, Katz M, Ozelius LJ, Bressman S, Saunders-Pullman R, Comella C, Klingman J, Nelson LM, Van Den Eeden SK, Tanner CM (2020) Cervical dystonia incidence and diagnostic delay in a multiethnic population. Mov Disord 35(3):450\u2013456","journal-title":"Mov Disord"},{"key":"378_CR15","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1002\/mds.20376","volume":"20","author":"NI Mejia","year":"2005","unstructured":"Mejia NI, Vuong KD, Jankovic J (2005) Longterm botulinum toxin efficacy, safety, and immunogenicity. Mov Disord 20:592\u2013597","journal-title":"Mov Disord"},{"issue":"3","key":"378_CR16","doi-asserted-by":"publisher","first-page":"e000881","DOI":"10.1136\/bmjopen-2012-000881","volume":"2","author":"VP Misra","year":"2012","unstructured":"Misra VP, Ehler E, Zakine B, Maisonobe P, Simonetta-Moreau M, Interest In CD Group (2012) Factors influencing response to Botulinum toxin type A in patients with idiopathic cervical dystonia: results from an international observational study. BMJ Open 2(3):e000881","journal-title":"BMJ Open"},{"issue":"12","key":"378_CR17","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1002\/mds.26817","volume":"31","author":"SA Norris","year":"2016","unstructured":"Norris SA, Jinnah HA, Espay AJ, Klein C, Br\u00fcggemann N, Barbano RL, Malaty IA, Rodriguez RL, Vidailhet M, Roze E, Reich SG, Berman BD, LeDoux MS, Richardson SP, Agarwal P, Mari Z, Ondo WG, Shih LC, Fox SH, Berardelli A, Testa CM, Cheng FC, Truong D, Nahab FB, Xie T, Hallett M, Rosen AR, Wright LJ, Perlmutter JS (2016) Clinical and demographic characteristics related to onset site and spread of cervical dystonia. Mov Disord 31(12):1874\u20131882","journal-title":"Mov Disord"},{"issue":"9","key":"378_CR18","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.1007\/s00415-019-09402-0","volume":"266","author":"RM Ortiz","year":"2019","unstructured":"Ortiz RM, Scheperjans F, Mertsalmi T, Pekkonen E (2019) Comorbidity and retirement in cervical dystonia. J Neurol 266(9):2216\u20132223","journal-title":"J Neurol"},{"issue":"5","key":"378_CR19","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1055\/s-0028-1109416","volume":"77","author":"G Reichel","year":"2009","unstructured":"Reichel G, Stenner A, Jahn A (2009) The phenomenology of cervical dystonia. Fortschr Neurol Psychiatr 77(5):272\u2013277","journal-title":"Fortschr Neurol Psychiatr"},{"key":"378_CR20","first-page":"155","volume":"33","author":"LL Simpson","year":"1981","unstructured":"Simpson LL (1981) The origin, structure, and pharmacologic activity of botulinum toxin. Pharmacol Rev 33:155\u2013188","journal-title":"Pharmacol Rev"},{"key":"378_CR21","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.parkreldis.2019.06.009","volume":"65","author":"M Tinazzi","year":"2019","unstructured":"Tinazzi M, Squintani GM, Bhatia KP, Segatti A, Donato F, Valeriani M, Erro R (2019) Pain in cervical dystonia: evidence of abnormal inhibitory control. Parkinsonism Relat Disord 65:252\u2013255","journal-title":"Parkinsonism Relat Disord"},{"key":"378_CR22","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1007\/s00702-020-02245-4","volume":"127","author":"M Tinazzi","year":"2020","unstructured":"Tinazzi M, Erro R, Mascia MM, Esposito M, Ercoli T, Ferrazzano G, Di Biasio F, Pellicciari R, Eleopra R, Bono F, Bertolasi L, Barone P, Scaglione CLM, Pisani A, Altavista MC, Cotelli MS, Ceravolo R, Cossu G, Zibetti M, Moja MC, Girlanda P, Maderna L, Albanese A, Petracca M, Magistrelli L, Misceo S, Minafra B, Romano M, Squintani GM, Modugno N, Aguggia M, Cassano D, Castagna A, Morgante F, Berardelli A, Defazio G (2020) Demographic and clinical determinants of neck pain in idiopathic cervical dystonia. J Neural Transm (Vienna) 127:1435\u20131439","journal-title":"J Neural Transm (vienna)"},{"issue":"4","key":"378_CR23","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s13760-016-0634-1","volume":"116","author":"S Tomic","year":"2016","unstructured":"Tomic S, Petkovic I, Pucic T, Resan B, Juric S, Rotim T (2016) Cervical dystonia and quality of life. Acta Neurol Belg 116(4):589\u2013592","journal-title":"Acta Neurol Belg"},{"issue":"5","key":"378_CR24","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.parkreldis.2010.03.002","volume":"16","author":"D Truong","year":"2010","unstructured":"Truong D, Brodsky M, Lew M, Brashear A, Jankovic J, Molho E, Orlova O, Timerbaeva S (2010) Long-term efficacy and safety of botulinum toxin type A (Dysport) in cervical dystonia. Parkinsonism Relat Disord 16(5):316\u2013323","journal-title":"Parkinsonism Relat Disord"},{"key":"378_CR25","doi-asserted-by":"crossref","unstructured":"W\u00f6llner J, Weise D, Leplow B (2021) Subjective versus objective symptom intensities ratings in\u00a0cervical\u00a0dystonia\u00a0and hemifacial spasm across a\u00a0botulinum\u00a0neurotoxin cycle. Brain Behav e02023","DOI":"10.1002\/brb3.2023"}],"container-title":["Neurotoxicity Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-021-00378-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12640-021-00378-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-021-00378-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,12]],"date-time":"2021-07-12T04:29:18Z","timestamp":1626064158000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12640-021-00378-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,29]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["378"],"URL":"https:\/\/doi.org\/10.1007\/s12640-021-00378-2","relation":{},"ISSN":["1029-8428","1476-3524"],"issn-type":[{"value":"1029-8428","type":"print"},{"value":"1476-3524","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,29]]},"assertion":[{"value":"17 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the Institutional Review Board of Sheba Medical Center (protocol code 7080\u201320, date of approval 11.06.2020).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional Review Board Statement"}},{"value":"Since this study is a retrospective one, the requirement for informed consent contingent on a de-identified analysis of the study database was waived.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}},{"value":"Prof. Sharon Hassin-Baer, Dr. Simon Israeli-Korn, and Dr. Gilad Yahalom received consultancy fees from Abbvie Biopharmaceuticals Inc. and Medison Pharma. No other disclosures were reported.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}